Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are filing herewith a transcript of the conference call held on Monday, November 12, 2018 at 02.30 P.M. local time, to discuss the Company's unaudited financial results (Stand-alone and Consolidated) for Quarter / Half Year ended September 30, 2018.... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Sachin Salvi, General Manager-Finance, would be participating at IDFC Securities Annual Investor Conference 'The Stock called India' organized by M/s. IDFC Securities Limited, at Hotel Grand Hyatt, Mumbai, on Wednesday, 21st November 2018, where he would be meeting various investors in between 2.00 P.M and 6.00 P.M.... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Sachin Salvi, General Manager-Finance, would be participating at IDFC Securities Annual Investor Conference 'The Stock called India' organized by M/s. IDFC Securities Limited, at Hotel Grand Hyatt, Mumbai, on Wednesday, 21st November 2018, where he would be meeting various investors in between 2.00 P.M and 6.00 P.M.... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference call for the Indian and overseas analysts has been arranged by our management to discuss the Company's financial results for Quarter / Half Year ended September 30, 2018, on Monday, November 12, 2018 at 2.30 P.M. local time. Dr. A. Velumani, Chairman & Managing Director, Mr. A. Sundararaju, Executive Director... Announcement under Regulation 30 (LODR)-Investor Presentation
We are forwarding copy of Presentation on Quarterly Results of our company for the quarter / half year ended 30-09-2018. Please note that this is only uploaded in our website, and is not being distributed or advertised in newspapers or otherwise publicised. Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are forwarding copy of Presentation on Quarterly Results of our company for the quarter / half year ended 30-09-2018. Please note that this is only uploaded in our website, and is not being distributed or advertised in newspapers or otherwise publicised. Outcome of Board Meeting
This is to inform you that the Board of Directors of the Company, at their meeting held today, approved the unaudited Financial Results (Stand-alone and Consolidated) for the Quarter / Half year ended September 30, 2018. The Stand-alone and Consolidated unaudited financial results for the quarter / half year ended September 30, 2018, along with the Limited Review Reports, are attached pursuant to Regulation 33 (3) (a) to (c) of SEBI... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Suney Hindocha and Mr. Edward Lam, Fund Managers of Somerset Capital Management, UK, would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Anand Velumani, Director of our subsidiary company, Nueclear Healthcare Ltd., at our office by 9.30 A.M. on Thursday, November 22, 2018.... Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Mr. Stephen Farley, Managing Partner and Mr. Andrei Stetsenko, Partner of Farley Capital, New York would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Anand Velumani, Director of our subsidiary company, Nueclear Healthcare Ltd., at our office by 9.30 A.M. on Thursday, November 15, 2018.... Closure of Trading Window
We have intimated to you by a separate letter about the meeting of the Board of Directors scheduled to be held on Saturday, November 03, 2018, to consider and approve the Unaudited financial results for the quarter / half year ended 30-09-2018. In this regard, we would like to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, and in accordance with the Company's Code relating to prohibition...